| Kelly Lynn Schickling, | |
|
772 N Townville St, Seneca, SC 29678-2645 | |
| (864) 886-9300 | |
| (864) 886-9399 |
| Full Name | Kelly Lynn Schickling |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 772 N Townville St, Seneca, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851890016 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 308547 (New York) | Secondary |
| 363LA2200X | Nurse Practitioner - Adult Health | 25891 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prisma Health Oconee Memorial Hospital | Seneca, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prisma Health University Medical Group | 8325950983 | 2201 |
News Archive
Chromatin Inc. announced today that they have reached the first milestone in their research collaboration with Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company. This collaboration is focused on developing a novel combination of Chromatin's Mini-Chromosomes with Dow AgroSciences' EXZACT Precision Technology.
TLC Vision announced today plans for a continued presence in Southern California, from Los Angeles to San Diego. The renewed commitment includes an agreement to maintain the long-standing relationship with Drs. Alan M. Berg and Robert E. Feinfield, which forms The Berg-Feinfield/TLC Laser Eye Centers located throughout the Los Angeles area.
KAEL-GemVax, a leading oncology vaccine company, today announced, through its subsidiary GemVax A.S, encouraging interim progress from the UK-based Phase III TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in pancreatic cancer. The company also strongly believes GV1001 has major "blockbuster" potential as a universal therapeutic cancer vaccine and is developing a strong pipeline for other indications, including lung and liver cancer and melanoma.
Scientists at the Morgridge Institute for Research have isolated a natural chemical that acts as a potent kryptonite against schistosomes, the parasitic worms that burrow through human skin and cause devastating health problems.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Diovan (valsartan), the most prescribed ARB (angiotensin receptor blocker) in the US and worldwide, for a new indication to reduce cardiovascular death in patients at high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.
› Verified 1 days ago
| Entity Name | Prisma Health University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295763217 PECOS PAC ID: 8325950983 Enrollment ID: O20031103000238 |
News Archive
Chromatin Inc. announced today that they have reached the first milestone in their research collaboration with Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company. This collaboration is focused on developing a novel combination of Chromatin's Mini-Chromosomes with Dow AgroSciences' EXZACT Precision Technology.
TLC Vision announced today plans for a continued presence in Southern California, from Los Angeles to San Diego. The renewed commitment includes an agreement to maintain the long-standing relationship with Drs. Alan M. Berg and Robert E. Feinfield, which forms The Berg-Feinfield/TLC Laser Eye Centers located throughout the Los Angeles area.
KAEL-GemVax, a leading oncology vaccine company, today announced, through its subsidiary GemVax A.S, encouraging interim progress from the UK-based Phase III TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in pancreatic cancer. The company also strongly believes GV1001 has major "blockbuster" potential as a universal therapeutic cancer vaccine and is developing a strong pipeline for other indications, including lung and liver cancer and melanoma.
Scientists at the Morgridge Institute for Research have isolated a natural chemical that acts as a potent kryptonite against schistosomes, the parasitic worms that burrow through human skin and cause devastating health problems.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Diovan (valsartan), the most prescribed ARB (angiotensin receptor blocker) in the US and worldwide, for a new indication to reduce cardiovascular death in patients at high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Lynn Schickling, 300 E Mcbee Ave Fl 4, Greenville, SC 29601-2842 Ph: (864) 522-8603 | Kelly Lynn Schickling, 772 N Townville St, Seneca, SC 29678-2645 Ph: (864) 886-9300 |
News Archive
Chromatin Inc. announced today that they have reached the first milestone in their research collaboration with Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company. This collaboration is focused on developing a novel combination of Chromatin's Mini-Chromosomes with Dow AgroSciences' EXZACT Precision Technology.
TLC Vision announced today plans for a continued presence in Southern California, from Los Angeles to San Diego. The renewed commitment includes an agreement to maintain the long-standing relationship with Drs. Alan M. Berg and Robert E. Feinfield, which forms The Berg-Feinfield/TLC Laser Eye Centers located throughout the Los Angeles area.
KAEL-GemVax, a leading oncology vaccine company, today announced, through its subsidiary GemVax A.S, encouraging interim progress from the UK-based Phase III TeloVac study of its anti-telomerase therapeutic cancer vaccine GV1001 in pancreatic cancer. The company also strongly believes GV1001 has major "blockbuster" potential as a universal therapeutic cancer vaccine and is developing a strong pipeline for other indications, including lung and liver cancer and melanoma.
Scientists at the Morgridge Institute for Research have isolated a natural chemical that acts as a potent kryptonite against schistosomes, the parasitic worms that burrow through human skin and cause devastating health problems.
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Diovan (valsartan), the most prescribed ARB (angiotensin receptor blocker) in the US and worldwide, for a new indication to reduce cardiovascular death in patients at high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.
› Verified 1 days ago
Elise Barbara Babineau, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 390 Keowee School Rd, Seneca, SC 29672 Phone: 864-884-7129 Fax: 864-882-7240 | |
Carol Meltzer Beckenhauer, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 12016 N Radio Station Rd, Seneca, SC 29678 Phone: 864-882-6141 Fax: 864-882-6680 | |
Shana M Collins-smith, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 12016 N Radio Station Rd, Seneca, SC 29678 Phone: 864-882-6141 Fax: 864-882-6680 | |
Adam Christopher Campbell, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10630 Clemson Blvd Ste 100, Seneca, SC 29678 Phone: 864-482-6000 | |
Mrs. Jessica Ann Mullis, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 263 Stone Pond Way, Seneca, SC 29678 Phone: 803-810-7054 | |
Vanessa Anne Smith, A-GNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 390 Keowee School Rd, Seneca, SC 29672 Phone: 864-885-7129 Fax: 864-882-7240 | |
Tracie D Smith, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Omni Dr, Suite B, Seneca, SC 29672 Phone: 864-482-2350 Fax: 864-482-2355 |